Resultado da Busca
PubMed® comprises more than 37 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.
15 de ago. de 2023 · PubMed is a free resource supporting the search and retrieval of biomedical and life sciences literature with the aim of improving health–both globally and personally. The PubMed database contains more than 37 million citations and abstracts of biomedical literature.
PubMed Central ® (PMC) is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM)
NCBI News & Blog. Upcoming Changes to NCBI Taxonomy Classifications. 04 Jun 2024. NCBI is continually making improvements to our Taxonomy resource in response to new data and changes in biological nomenclature and classification.
21 de mai. de 2024 · PubMed User Guide. Last update: May 21, 2024. Follow PubMed New and Noteworthy for brief announcements highlighting recent enhancements and changes to PubMed. FAQs. How can I get the full text article? What if the link to the full text is not working ? How do I search by author? How do I search by journal name? How do I find a specific citation?
PubMed is a free online database of biomedical and life sciences literature from MEDLINE, journals, and books. Search by keyword, author, or topic.
At any given test delay, an increase in the interstudy gap at first increased, and then gradually reduced, final test performance. The optimal gap increased as test delay increased. However, when measured as a proportion of test delay, the optimal gap declined from about 20 to 40% of a 1-week test delay to about 5 to 10% of a 1-year test delay.
PubMed® comprises more than 37 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.
31 de dez. de 2020 · A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines.
24 de jan. de 2024 · Our understanding of COVID-19 vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts. Published reports from the original randomized phase 3 trials concluded that the COVID-19 mRNA vaccines could greatly reduce COVID-19 symptoms.
